Prevalence and risk factors of fatty liver disease in young and middle-aged population: One center study in southwestern China

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 2, 2014, Pages 358-364

  Xiao, Shao Jun ^a   Fu, Guang Jian ^a   Lv, Ya Lan ^a   Zhong, Xiao Ni ^a   Wang, Run Hua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Fatty liver disease; Metabolic syndrome; Prevalence; Risk factors; Young and middle aged

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL LIVER DISEASE; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BODY MASS; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE SEVERITY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOCHOLESTEROLEMIA; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; URBAN AREA; WAIST TO HEIGHT RATIO; YOUNG ADULT; ADOLESCENT; AGE; FATTY LIVER DISEASE; LEUKOCYTE COUNT; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; URBAN POPULATION; YOUNG AND MIDDLE-AGED;

FATTY LIVER DISEASE; METABOLIC SYNDROME; PREVALENCE; RISK FACTORS; YOUNG AND MIDDLE-AGED;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84907290726     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12334     Document Type: Article

References (27)

1. Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum. Pathol. 2010; 41: 425-430.
2. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50: 1282-1293.
3. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jarvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig. Liver Dis. 2010; 42: 320-330.
4. Williamson RM, Price JF, Glancy S etal. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011; 34: 1139-1144.
5. Agarwal AK, Jain V, Singla S etal. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J. Assoc. Physicians India 2011; 59: 351-354.
6. Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009; 203: 581-586.
7. Fan JG, Saibara T, Chitturi S etal. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J. Gastroenterol. Hepatol. 2007; 22: 794-800.
8. Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. J. Dig. Dis. 2012; 13: 153-160.
9. Chen CH, Huang MH, Yang JC etal. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J. Clin. Gastroenterol. 2006; 40: 745-752.
10. Shen L, Fan JG, Shao Y etal. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J. Gastroenterol. 2003; 9: 1106-1110.
11. Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J. Gastroenterol. Hepatol. 2007; 22: 663-668.
12. Dai H, Chu L, Song S etal. Prevalence of and risk factors for fatty liver disease in a professional population of Wuhan, China. Public Health 2009; 123: 545-548.
13. Fan JG, Zhu J, Li XJ etal. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 2005; 43: 508-514.
14. Wan YP, Xu RY, Fang H, Lu LP, Zhang XM, Cai W. [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai]. Zhonghua Gan Zang Bing Za Zhi 2007; 15: 644-648.
15. Yang Z, Wang X, Wen J etal. Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population. Arch. Med. Sci. 2011; 7: 665-672.
16. Hu X, Huang Y, Bao Z etal. Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units. BMC Gastroenterol. 2012; 12: 123.
17. Shi L, Liu ZW, Li Y etal. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed. Environ. Sci. 2012; 25: 383-391.
18. Esteghamati A, Jamali A, Khalilzadeh O etal. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol. Metab. Syndr. 2010; 2: 65-71.
19. Fan JG, Zhu J, Li XJ etal. Fatty liver and the metabolic syndrome among Shanghai adults. J. Gastroenterol. Hepatol. 2005; 20: 1825-1832.
20. Hsiao PJ, Kuo KK, Shin SJ etal. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 2007; 22: 2118-2123.
21. Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J. Hepatol. 2010; 53: 1146-1147.
22. Marchesini G, Brizi M, Bianchi G etal. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
23. Lee YJ, Lee HR, Shim JY, Moon BS, Lee JH, Kim JK. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig. Liver Dis. 2010; 42: 888-894.
24. Kanter JE, Bornfeldt KE. Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. Trends Endocrinol. Metab. 2012; 24: 137-144.
25. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
26. Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J. Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease. Gastroenterol. Res. Pract. 2012; 2012: Article ID 362147, 6 pages. doi: 10.1155/2012/362147.
27. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J. Hepatol. 2009; 51: 1061-1067.